FacultyFaculty/Author Profile

John Siracusa

Akin Gump Strauss Hauer & Feld LLP

Washington, DC, USA


John A. Siracusa represents a broad­based group of clients in the health care industry, where he focuses on Medicare and Medicaid coverage and reimbursement, health care fraud and abuse, and internal and government investigations.

Practice & Background

Mr. Siracusa provides legal and policy advice to pharmaceutical and medical device manufacturers; hospitals and health systems; major academic medical centers; dialysis companies; skilled nursing facilities; durable medical equipment suppliers; pharmacy benefit management companies; lenders and investors; and a variety of other health­care related entities.

Mr. Siracusa counsels clients on health care fraud and abuse laws, including the Anti­Kickback Statute and Stark Law. He routinely advises clients on structuring business arrangements to comply with both state and federal fraud and abuse laws, as well as corporate practice of medicine prohibitions and other statutory and regulatory requirements. Mr. Siracusa also assists clients in conducting internal investigations and responding to governmental inquiries, and has defended clients in lawsuits arising under the False Claims Act.

Mr. Siracusa also focuses on a variety of Medicare and Medicaid coverage and payment matters, including the legal and regulatory implications of delivery system reforms enacted under the Affordable Care Act. He has also successfully represented hospitals in complex Medicare reimbursement disputes with the federal government.

Prior to entering law school, Mr. Siracusa worked at the Biotechnology Industry Organization (BIO), where he led the trade association’s health policy efforts related to coverage, coding and reimbursement for innovative biopharmaceuticals under Medicare, Medicaid and other federal health care programs. Before that, he worked for a health care consulting firm, where he developed health policy, pricing, and market access strategies for manufacturers of pharmaceuticals, diagnostics and medical devices. During law school, Mr. Siracusa interned with the Centers for Medicare and Medicaid Services (CMS) Division of the Office of the General Counsel at the U.S. Department of Health and Human Services (HHS).

Mr. Siracusa received his J.D. cum laude in 2011 from the Georgetown University Law Center, where he was the recipient of the ABA­BNA Award for Excellence in the Study of Health Law.

Areas of Experience

Education

DE GRE E S

  • J.D., Georgetown University Law Center, cum laude, 2011 A.B.,
  • Duke University, 2003

Admissions

B A R

  • District of Columbia
  • Maryland

Publications

OIG Releases New Proposals on Anti­kickback Statute Safe Harbors, Exceptions to the CMP Law and the Gainsharing Prohibition by Jorge Lopez Jr., Robert S. Salcido, Kelly M. Cleary, Caitlin McCormick, John A. Siracusa.

OIG Releases New Proposals on Anti­kickback Statute Safe Harbors, Exceptions to the CMP Law and the Gainsharing Prohibition

 Media Mentions & Press Releases

FEB 10        Financial Fraud Law Report Publishes Akin Gump Analysis of HHS Rule

John Siracusa is associated with the following items:
CHB Chapters  CHB Chapters Medicaid Drug Rebate Program Notice for Participating Drug Manufacturers (July 14, 2016) - Life Sciences 2016: Navigating Legal Challenges in the Drug and Device Industries, Wednesday, November 02, 2016
Medicare Clinical Diagnostic Laboratory Tests Payment System Final Rule (June 17, 2016) - Life Sciences 2016: Navigating Legal Challenges in the Drug and Device Industries, Wednesday, November 02, 2016
Medicare Program; Part B Drug Payment Model; Proposed Rule, Department of Health and Human Services, Centers for Medicare & Medicaid Services, 42 CFR Part 511 (March 2016) - Life Sciences 2016: Navigating Legal Challenges in the Drug and Device Industries, Wednesday, November 02, 2016
Notice of Proposed Rulemaking for Bundled Payment Models for High-Quality, Coordinated Cardiac and Hip Fracture Care (July 25, 2016) - Life Sciences 2016: Navigating Legal Challenges in the Drug and Device Industries, Wednesday, November 02, 2016
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.